Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer
Clinical trial NCT01884623 · COMPLETED
Trial details
- NCT number
- NCT01884623
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-06
- Primary completion
- 2021-10-12
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.